Alopecia

Healio was on site at this year’s American Academy of Dermatology Annual Meeting, covering a range of important dermatology news, including updates to atopic dermatitis, psoriasis and hair disorders.

BOSTON — For patients with frontal fibrosing alopecia, the extent of eyebrow loss can predict severity and refractory disease, according to a poster presented at the American Academy of Dermatology Annual Meeting.

Frontal fibrosing alopecia was found to be limited to the scalp with inflammatory milieu linked to fibrosis and no systemic inflammation, suggesting possible treatment with immune-targeting therapeutics, according to a genetic analysis.

Female sex was identified as a baseline predictor of increased odds of both nausea and alopecia in patients with rheumatoid arthritis beginning methotrexate treatment, according to data presented at ACR Convergence 2021.

Traction alopecia can be reversed or reduced when clinicians are mindful of culturally sensitive practices and recommend low-risk hair styles, according to a poster presented at the Skin of Color Update virtual meeting.

Patients with frontal brosing alopecia who received higher doses of oral dutasteride experienced the greatest improvement in hairline recession, according to a study.

Patients with alopecia areata who were treated with baricitinib experienced improvement in eyebrow and eyelash growth before scalp hair regrowth, according to a poster presented at AAD VMX 2021.

Patients with alopecia are often stigmatized due to their condition, with the stigma varying depending on the alopecia severity, according to a study.

Alopecia, a condition with various subtypes and etiologies, is a “common and distressing clinical complaint in the primary care setting,” researchers wrote in Frontiers in Medicine.

Results of a case-control study in Brazil indicated that frontal fibrosing alopecia was associated with use of ordinary facial soap and moisturizers.